Skip to Main Content

Author Details

Andy G Lynch
University of St Andrews
2004
82
38
PMIDPaper TitleJournal TitlePublished Year
35978291Low-cost and clinically applicable copy number profiling using repeat DNA.BMC Genomics2022
35842220Identification of plasma proteins associated with oesophageal cancer chemotherapeutic treatment outcomes using SWATH-MS.J Proteomics2022
35659150Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study.Eur Urol2022
35450835Microbiomes of Urine and the Prostate Are Linked to Human Prostate Cancer Risk Groups.Eur Urol Oncol2022
33303580CamGFR v2: A New Model for Estimating the Glomerular Filtration Rate from Standardized or Non-standardized Creatinine in Patients with Cancer.Clin Cancer Res2021
34936871Resolving the immune landscape of human prostate at a single-cell level in health and cancer.Cell Rep2021
32431871Different laterality indexes are poorly correlated with one another but consistently show the tendency of males and females to be more left- and right-lateralized, respectively.R Soc Open Sci2020
30664780Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesions.Nat Med2019
28870782The role of TET-mediated DNA hydroxymethylation in prostate cancer.Mol Cell Endocrinol2018
30177810Publisher Correction: Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data.Sci Rep2018
29358629Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data.Sci Rep2018
29662167Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.Nat Genet2018
29656891Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal.Cell2018
28753852DESNT: A Poor Prognosis Category of Human Prostate Cancer.Eur Urol Focus2018
27117390The importance of DNA methylation in prostate cancer development.J Steroid Biochem Mol Biol2017
28138154Corrigendum: Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance.Nat Genet2017
28292578Corrigendum to "Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study" [EBioMedicine 2 (9) (2015) 1133-1144].EBioMedicine2017
28286059Mining Human Prostate Cancer Datasets: The "camcAPP" Shiny App.EBioMedicine2017
28465312A comparative analysis of whole genome sequencing of esophageal adenocarcinoma pre- and post-chemotherapy.Genome Res2017
28974564Corrigendum: A comparative analysis of whole genome sequencing of esophageal adenocarcinoma pre- and post-chemotherapy.Genome Res2017
28945760Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data.PLoS Genet2017
28810143Genomic Evolution of Breast Cancer Metastasis and Relapse.Cancer Cell2017
28851861Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer.Nat Commun2017
28686534New Model for Estimating Glomerular Filtration Rate in Patients With Cancer.J Clin Oncol2017
27578825Whole blood mRNA in prostate cancer reveals a four-gene androgen regulated panel.Endocr Relat Cancer2016
26572708The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer.Eur Urol2016
27595477Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance.Nat Genet2016
27594985Whole-genome sequencing of nine esophageal adenocarcinoma cell lines.F1000Res2016
25560400HES5 silencing is an early and recurrent change in prostate tumourigenesis.Endocr Relat Cancer2015
26657335Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic Target.J Natl Cancer Inst2015
26647970A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing.Nat Commun2015
26501111Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study.EBioMedicine2015
26962434Crambled: A Shiny application to enable intuitive resolution of conflicting cellularity estimates.F1000Res2015
26035357Epigenetic and oncogenic regulation of SLC16A7 (MCT2) results in protein over-expression, impacting on signalling and cellular phenotypes in prostate cancer.Oncotarget2015
26192915Whole-genome sequencing provides new insights into the clonal architecture of Barrett's esophagus and esophageal adenocarcinoma.Nat Genet2015
258538005-hydroxymethylcytosine marks promoters in colon that resist DNA hypermethylation in cancer.Genome Biol2015
26018901Corrigendum: analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.Nat Genet2015
25790137Phenotype specific analyses reveal distinct regulatory mechanism for chronically activated p53.PLoS Genet2015
25730763Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.Nat Genet2015
25722372multiSNV: a probabilistic approach for improving detection of somatic point mutations from multiple related tumour samples.Nucleic Acids Res2015
24952744Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis.Nat Genet2014
25452765Quantifying the impact of inter-site heterogeneity on the distribution of ChIP-seq data.Front Genet2014
25271376Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer.Elife2014
25082706Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes.Science2014
23880827Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stress.Br J Cancer2013
22522925The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.Nature2012
22912679Calling sample mix-ups in cancer population studies.PLoS One2012
21245054BayesPeak--an R package for analysing ChIP-seq data.Bioinformatics2011
22144879BeadArray expression analysis using bioconductor.PLoS Comput Biol2011
21602788The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis.EMBO J2011
  • 1 - 50 of 82

Recommended Authors

H??ctor Corrada Bravo
University of Maryland College Park, College Park
Career Start Year 2009
Number of shared co-authors 2
Brandy Klotzle
Departments of Bioinformatics and Clinical Genomics, Illumina Inc.
Career Start Year 2009
Number of shared co-authors 7
Harmen J G van de Werken
Department of Immunology Erasmus University Medical Center
Career Start Year 2006
Number of shared co-authors 9
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 34
Svitlana Tyekucheva
Dana-Farber Cancer Institute
Career Start Year 2006
Number of shared co-authors 4
Wendell D Jones
Department of Bioinformatics and Clinical Systems
Career Start Year 2006
Number of shared co-authors 3
Kasper D Hansen
Johns Hopkins University School of Medicine
Career Start Year 2004
Number of shared co-authors 5
Terence P Speed
Walter and Eliza Hall Institute of Medical Research
Career Start Year 2003
Number of shared co-authors 7
Leslie Cope
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 4
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Syed Haider
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 31
Mikhail G Dozmorov
Virginia Commonwealth University
Career Start Year 2001
Number of shared co-authors 1
Peter J Park
Harvard Medical School
Career Start Year 2001
Number of shared co-authors 22
Mark A van de Wiel
Amsterdam University Medical Centers (Amsterdam UMC)
Career Start Year 2001
Number of shared co-authors 6
Rafael A Irizarry
Dana-Farber Cancer Institute
Career Start Year 2001
Number of shared co-authors 11
Andrea Sboner
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 10
Shawn Levy
HudsonAlpha Institute for Biotechnology
Career Start Year 1999
Number of shared co-authors 4
Mark D Robinson
University of Zurich
Career Start Year 1997
Number of shared co-authors 9
Steven J M Jones
University of British Columbia
Career Start Year 1995
Number of shared co-authors 56
Wim Van Criekinge
Ghent University
Career Start Year 1995
Number of shared co-authors 2
Wolfgang Huber
Technische Universitat Munchen
Career Start Year 1995
Number of shared co-authors 14
Marco A Marra
University of British Columbia
Career Start Year 1993
Number of shared co-authors 60
Adam B Olshen
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 4
Gordon K Smyth
The University of Melbourne
Career Start Year 1992
Number of shared co-authors 7
Aleksandar Milosavljevic
Baylor College of Medicine
Career Start Year 1991
Number of shared co-authors 7
Keith A Baggerly
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 4
Jean-Pierre A Kocher
Mayo Clinic
Career Start Year 1991
Number of shared co-authors 2
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 3
Jian-Bing Fan
Nanfang Hospital and Basic Medical College, Southern Medical University
Career Start Year 1987
Number of shared co-authors 16
Francesca Demichelis
University of Trento
Career Start Year 1969
Number of shared co-authors 16

Collaborators

Simon Tavar??
Irving Institute for Cancer Dynamics, Columbia University
Co-authored papers 28
Charlie E Massie
University of Cambridge
Co-authored papers 21
Mark J Dunning
The Medical School, The University of Sheffield
Co-authored papers 20
David E Neal
University of Oxford, John Radcliffe Hospital
Co-authored papers 19
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Co-authored papers 18
Hayley C Whitaker
University College London
Co-authored papers 14
Colin S Cooper
Norwich Medical School, University of East Anglia
Co-authored papers 12
Jonathan Kay
University College London
Co-authored papers 11
Rosalind A Eeles
The Institute of Cancer Research
Co-authored papers 10
Daniel S Brewer
University of Washington, USA Institute for Stem Cell and Regenerative Medicine
Co-authored papers 10
Ian G Mills
Queen's University Belfast
Co-authored papers 9
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Co-authored papers 9
Adam Butler
Wellcome Sanger Institute
Co-authored papers 9
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 8
Alastair D Lamb
University of Oxford
Co-authored papers 8
Peter J Campbell
Wellcome Sanger Institute
Co-authored papers 8
Matthew D Eldridge
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 8
Vincent J Gnanapragasam
University of Cambridge
Co-authored papers 8
Keiran Raine
Wellcome Sanger Institute
Co-authored papers 8
Hayley J Luxton
University College London
Co-authored papers 8
Lawrence Bower
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 7
Nimish Shah
Cambridge University Hospitals NHS Foundation Trust
Co-authored papers 7
Jeremy Clark
Norwich Medical School, University of East Anglia
Co-authored papers 7
Gunes Gundem
Memorial Sloan Kettering Cancer Center
Co-authored papers 7
Christopher S Foster
The Institute of Cancer Research
Co-authored papers 7
Jon Teague
Wellcome Sanger Institute
Co-authored papers 7
Ludmil B Alexandrov
Moores Cancer Center, university of california san diego
Co-authored papers 6
Peter Van Loo
The Francis Crick Institute
Co-authored papers 6
Ultan McDermott
Wellcome Sanger Institute
Co-authored papers 6
David Jones
Wellcome Sanger Institute
Co-authored papers 6
Release 1.2